BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

42 related articles for article (PubMed ID: 2453117)

  • 1. Percutaneous Nephrostomy as a Procedure in the Treatment of Urinary Tract Obstruction - Experiences in the University Clinic of Urology in Skopje.
    Trifunovski A; Severova G; Atanasova A; Janculev J; Stankov V; Stavridis S; Saidi S; Brzanov AG; Ambardjieva M; Dohchev S
    Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2024 Mar; 45(1):31-40. PubMed ID: 38575377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival Outcome of Urinary Diversion in Advanced Cervical Cancer Patients with Hydronephrosis.
    Dhani FK; Daryanto B; Seputra KP
    Asian Pac J Cancer Prev; 2023 Aug; 24(8):2641-2646. PubMed ID: 37642049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The challenging management of malignant ureteral obstruction: Analysis of a series of 188 cases.
    Artiles Medina A; Laso García I; González Tello F; Álvarez Rodríguez S; Hevia Palacios M; Mata Alcaraz M; Mínguez Ojeda C; Arias Funez F; Gómez Dos Santos V; Burgos Revilla FJ
    Curr Urol; 2024 Mar; 18(1):34-42. PubMed ID: 38505156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Percutaneous nephrostomy catheter-related infections in patients with gynaecological cancers: a multidisciplinary algorithmic approach.
    Szvalb AD; Marten C; Cain K; Taylor JS; Huang SY; Jiang Y; Raad II; Viola GM
    J Hosp Infect; 2023 Nov; 141():99-106. PubMed ID: 37696471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case report of sepsis associated coagulopathy after percutaneous nephrostomy.
    Duan J; Ye T; Yang Y; Zhou Y; Yang S; Wang Y
    BMC Urol; 2024 May; 24(1):113. PubMed ID: 38807082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of treatment strategies for patients with advanced cervical cancer and obstructive renal failure after a failed ureteral catheterization.
    Xin S; Jianbo Y; Chen J
    Asian J Surg; 2023 Dec; 46(12):5639-5640. PubMed ID: 37597987
    [No Abstract]   [Full Text] [Related]  

  • 7. The implications when offering percutaneous nephrostomy for the management of malignant obstructive uropathy secondary to urological malignancy: can we be more selective?
    Osinibi E; Doan H; Mercado-Campero A; Abbaraju J; Masood S; Madaan S
    Ther Adv Urol; 2023; 15():17562872231207729. PubMed ID: 37901283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ureteral decompression in advanced nonurologic malignancies.
    Donat SM; Russo P
    Ann Surg Oncol; 1996 Jul; 3(4):393-9. PubMed ID: 8790853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Management of ureteral obstruction : Value of percutaneous nephrostomy and ureteral stents].
    Netsch C; Becker B; Gross AJ
    Urologe A; 2016 Nov; 55(11):1497-1510. PubMed ID: 27787581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Percutaneous nephrostomy in gynecologic oncology patients.
    Soper JT; Blaszczyk TM; Oke E; Clarke-Pearson D; Creasman WT
    Am J Obstet Gynecol; 1988 May; 158(5):1126-31. PubMed ID: 2453117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Percutaneous nephrostomy in gynecologic oncology.
    Baker VV; Dudzinski MR; Fowler WC; Currie JL; Walton LA
    Am J Obstet Gynecol; 1984 Aug; 149(7):772-4. PubMed ID: 6465230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Percutaneous nephrostomy and ureteral stenting in gynecologic malignancies.
    Barton DP; Morse SS; Fiorica JV; Hoffman MS; Roberts WS; Cavanagh D
    Obstet Gynecol; 1992 Nov; 80(5):805-11. PubMed ID: 1407920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of percutaneous nephrostomy in gynecologic oncology.
    Mann WJ; Hatch KD; Taylor PT; Partridge EM; Orr JW; Shingleton HM
    Gynecol Oncol; 1983 Dec; 16(3):393-9. PubMed ID: 6654181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percutaneous nephrostomy for palliation of metastatic ureteral obstruction.
    Culkin DJ; Wheeler JS; Marsans RE; Nam SI; Canning JR
    Urology; 1987 Sep; 30(3):229-31. PubMed ID: 2442872
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.